1. Basic pathology and etiology of tumor and its microenvironment2. EPR effect and its implication in passive targeting of nanocarrier to the tumor3. pH sensitive carriers as delivery to tumor4. Temperature sensitive carrier temperature directed tumor cell eradication5. Magnetically responsive delivery into tumor environment6. Ligands used for tumor targeting7. Therapy targeting angiogenic potential of tumor8. Immunotherapy of cancer9. Chemical linkers: Potential approach to target tumor10. Cell penetrating peptide in cancer targeting11. Inorganic nanoparticles: A new avenue in improving diagnostics12. Development of photodynamic cancer therapy13. Therapeutics based on small interfering RNAs (siRNA)14. Aptamer conjugates: A new avenue15. Application of cancer stem cells in improving therapeutics16. Targeting breast cancer17. Lung cancer: improving efficacy and reducing side effects18. Colorectal cancer: and its targeting19. Hepatic cancer targeting20. Solid tumor: Addressing the problems associated21. Pancreatic cancer: Removing extracellular matrix barrier in delivery22. Targeting to the CNS: Approach for brain tumor23. Metastatic cancer: How one can address the therapeutic challenge24. Prostate cancer: Delivery aspect and prospect25. Leukemia: trends in treatment and how close we have achieved eradication26. Tumor imaging and its application in tumor targeted drug delivery27. 2D and 3D cell culture: Getting close to mimicking tumor microenvironment in vitro28. In vivo animal model for cancer: What have we learnt from chemical induced and xenograft models29. Nanosystem: regulatory aspects, clinical development and market potential